Proxybio
Latest round
- Seed
Last raised
- Jul 2021
Total raised
- Undisclosed
Investors
- 1
About Proxybio
Established in 2020 and based in Shenzhen, China, Proxybio is a biological technology company that focuses on drugs in the field of mRNA. The founder Dr. Jiaqi Lin has more than ten years of experience in nanobiological research. At present, the core team all come from laboratory of Massachusetts Institute of Technology. The company has a self-develop mRNA high-throughput synthesis platform which provides mRNA drug product for customer.
Who invested in Proxybio
1 investor across 1 round
See all investors in Proxybio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 5, 2021
Amount
Undisclosed
Investors
Questions about Proxybio
Who invested in Proxybio?
Proxybio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proxybio raised?
Proxybio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proxybio last raise money?
Proxybio's most recent round on record is a Seed, in Jul 2021.
What does Proxybio do?
Established in 2020 and based in Shenzhen, China, Proxybio is a biological technology company that focuses on drugs in the field of mRNA.
Where is Proxybio headquartered?
Proxybio is headquartered in Shenzhen, China.
Which VCs invest in companies like Proxybio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Proxybio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Proxybio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.